Aliases & Classifications for Postural Hypotension

MalaCards integrated aliases for Postural Hypotension:

Name: Postural Hypotension 54

Summaries for Postural Hypotension

NINDS : 54 Orthostatic hypotension is a sudden fall in blood pressure that occurs when a person assumes a standing position. It is due to a lesion of the baroreflex loop, which senses a change in blood pressure and adjusts heart rate and activates sympathetic nerve system fibers to cause the blood vessels to narrow and correct blood pressure. It may also be caused by hypovolemia (a decreased amount of blood in the body), resulting from the excessive use of diuretics, vasodilators, or other types of drugs, dehydration, or prolonged bed rest. The disorder may be associated with Addison's disease, diabetes, and certain neurological disorders including Multiple System Atrophy with Orthostatic Hypotension (formerly known as Shy-Drager syndrome), autonomic system neuropathies, and other dysautonomias. Symptoms, which generally occur after sudden standing, include dizziness, lightheadedness, blurred vision, and syncope (temporary loss of consciousness).

MalaCards based summary : Postural Hypotension is related to diabetic autonomic neuropathy and acromegaly. An important gene associated with Postural Hypotension is ABCB1 (ATP Binding Cassette Subfamily B Member 1), and among its related pathways/superpathways are HIF-1 signaling pathway and Amino Acid metabolism. The drugs Midodrine and Dopamine have been mentioned in the context of this disorder. Affiliated tissues include heart, spinal cord and brain, and related phenotypes are behavior/neurological and cardiovascular system

Related Diseases for Postural Hypotension

Diseases related to Postural Hypotension via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 99)
# Related Disease Score Top Affiliating Genes
1 diabetic autonomic neuropathy 30.9 DBH INS
2 acromegaly 29.3 INS SST
3 congestive heart failure 27.9 NPPA REN
4 pure autonomic failure 27.7 DBH DDC NPPA REN
5 parkinson disease, late-onset 11.1
6 baroreflex failure 11.0
7 neuropathy, hereditary sensory and autonomic, type iii 11.0
8 hereditary neuropathies 11.0
9 neuropathy 10.4
10 autonomic neuropathy 10.3
11 autonomic nervous system disease 10.3 DBH INS
12 early-onset schizophrenia 10.3 DBH INS
13 duodenal somatostatinoma 10.2 INS SST
14 postgastrectomy syndrome 10.2 INS SST
15 hyperinsulinemic hypoglycemia, familial, 2 10.2 INS SST
16 hyperpituitarism 10.2 INS SST
17 somatostatinoma 10.2 INS SST
18 dumping syndrome 10.2 INS SST
19 gastrinoma 10.2 INS SST
20 islet cell tumor 10.2 INS SST
21 endocrine pancreas disease 10.2 INS SST
22 pituitary-dependent cushing's disease 10.1 INS SST
23 pancreas disease 10.1 INS SST
24 idiopathic edema 10.1 INS NPPA
25 aging 10.1
26 pituitary gland disease 10.1 INS SST
27 hyperinsulinemic hypoglycemia 10.1 INS SST
28 duodenal ulcer 10.0 INS SST
29 synucleinopathy 10.0 DDC SST
30 autonomic dysfunction 10.0
31 syncope 10.0
32 gallbladder disease 10.0 INS SST
33 amyloidosis 10.0
34 renal hypertension 10.0 DBH REN
35 anhidrosis 9.9
36 cerebritis 9.9
37 hypoxia 9.9
38 adrenal cortex disease 9.8 REN SST
39 adrenal gland disease 9.8 REN SST
40 hepatic vascular disease 9.8 REN SST
41 apnea, obstructive sleep 9.8 INS REN
42 hyperthyroidism 9.8 INS SST
43 endocrine organ benign neoplasm 9.8 REN SST
44 hypoaldosteronism 9.8 NPPA REN
45 renal artery disease 9.8 NPPA REN
46 hypertension, diastolic 9.8 NPPA REN
47 microvascular complications of diabetes 3 9.7 INS REN
48 malignant hypertension 9.7 NPPA REN
49 alzheimer disease 9.7
50 lymphoma 9.7

Graphical network of the top 20 diseases related to Postural Hypotension:



Diseases related to Postural Hypotension

Symptoms & Phenotypes for Postural Hypotension

MGI Mouse Phenotypes related to Postural Hypotension:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.85 ABCB1 DBH DDC INS REN SST
2 cardiovascular system MP:0005385 9.8 ABCB1 DBH DDC INS NPPA REN
3 growth/size/body region MP:0005378 9.73 REN SST ABCB1 DBH DDC INS
4 homeostasis/metabolism MP:0005376 9.7 DBH DDC INS NPPA REN SST
5 nervous system MP:0003631 9.43 ABCB1 DBH DDC INS REN SST
6 renal/urinary system MP:0005367 8.92 DDC INS NPPA REN

Drugs & Therapeutics for Postural Hypotension

Drugs for Postural Hypotension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 343)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Midodrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 133163-28-7, 42794-76-3 4195
2
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-61-6, 62-31-7 681
3
Droxidopa Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 23651-95-8 443940
4
Maraviroc Approved, Investigational Phase 4 376348-65-1 3002977
5
Amlodipine Approved Phase 4,Phase 3 88150-42-9 2162
6
Celecoxib Approved, Investigational Phase 4,Phase 1 169590-42-5 2662
7
Losartan Approved Phase 4,Phase 1 114798-26-4 3961
8
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 1 58-93-5 3639
9
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
10
Norepinephrine Approved Phase 4,Phase 1,Phase 2 51-41-2 439260
11
Acetaminophen Approved Phase 4 103-90-2 1983
12
Tamsulosin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 106133-20-4 129211
13
Levodopa Approved Phase 4,Phase 3,Phase 2,Phase 1 59-92-7 6047
14
Methylphenidate Approved, Investigational Phase 4,Phase 1 113-45-1 4158
15
Moxonidine Approved, Investigational Phase 4 75438-57-2 4810
16
Irbesartan Approved, Investigational Phase 4,Phase 3 138402-11-6 3749
17
Angiotensin II Approved, Investigational Phase 4,Phase 3,Phase 1,Early Phase 1 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
18
Prednisone Approved, Vet_approved Phase 4,Not Applicable 53-03-2 5865
19
Xylometazoline Approved, Investigational Phase 4 526-36-3 5709
20
Naltrexone Approved, Investigational, Vet_approved Phase 4 16590-41-3 5360515
21 Mirabegron Approved Phase 4,Phase 2 223673-61-8 9865528
22
Silodosin Approved Phase 4,Phase 3 160970-54-7
23 diuretics Phase 4,Phase 3,Phase 2,Phase 1
24 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
25 Adrenergic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
26 Adrenergic Agonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
27 Adrenergic alpha-Agonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
28 Natriuretic Agents Phase 4,Phase 3,Phase 2,Phase 1
29 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
30 Neurotransmitter Uptake Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
31 Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
32 Hormones Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
33 Angiotensin Receptor Antagonists Phase 4,Phase 3,Phase 1
34 Dopamine Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
35 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
36 Vasoconstrictor Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
37 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 1,Not Applicable
38 Vasodilator Agents Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1
39 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
40 Antihypertensive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
41 Psychotropic Drugs Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
42 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
43 Antiparkinson Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
44 Pyridostigmine Bromide Phase 4,Phase 2,Phase 1 101-26-8
45 Analgesics Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
46 calcium channel blockers Phase 4,Phase 3,Phase 2,Phase 1
47 glucocorticoids Phase 4,Phase 2,Phase 3,Not Applicable
48 Central Nervous System Stimulants Phase 4,Phase 3,Phase 1,Not Applicable
49 Adrenergic alpha-1 Receptor Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
50 Adrenergic alpha-Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 200)
# Name Status NCT ID Phase Drugs
1 A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial) Unknown status NCT01589380 Phase 4 Fimasartan;Placebo
2 Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension Completed NCT01518946 Phase 4 Midodrine HCl;Placebo
3 Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension Completed NCT01515865 Phase 4 Midodrine HCl;Placebo
4 Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study Completed NCT02308124 Phase 4 Midodrine;Pyridostigmine Bromide;Midodrine + pyridostigmine
5 A Study for Patients With Neurogenic Orthostatic Hypotension Completed NCT00046475 Phase 4 Midodrine Hydrochloride
6 Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension Completed NCT00555880 Phase 4 Midodrine hydrochloride;Placebo
7 Comparision of Blood Pressure Variability Between Amlodipine and Losartan Completed NCT01964079 Phase 4 Amlodipine;Losartan
8 Adjuvant Analgesic Effects of Low Dose Tramadol/Acetaminophen Combination After Open Gynaecological Surgery Completed NCT00942565 Phase 4 tramadol/acetaminophen;acetaminophen
9 Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's Disease Completed NCT00914134 Phase 4 Levodopa infusion
10 AMISH : Aprovel for Management of Isolated Systolic Hypertension Completed NCT00264212 Phase 4 irbesartan and irbesartan-hydrochlorothiazide
11 Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc Completed NCT00853840 Phase 4 Maraviroc;Vardenafil;Maraviroc;Placebo
12 Stop Atherosclerosis in Native Diabetics Study Completed NCT00147251 Phase 4 FDA approved drugs to treat blood pressure and cholesterol
13 A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients Completed NCT00406848 Phase 4 duloxetine hydrochloride;placebo
14 Moxonidine for Prevention of Post-ablation AFib Recurrences Completed NCT01791699 Phase 4 Moxonidine;Placebo
15 Short-term Prednisone to Treat STA Study(SPTSS) Completed NCT01837433 Phase 4 Prednisone 1 week;Prednisone 6 weeks
16 Dawn Simulation and Postural Hypotension Recruiting NCT02632318 Phase 4
17 Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension Recruiting NCT02586623 Phase 4 Droxidopa capsules;Placebo capsules
18 Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH Recruiting NCT03350659 Phase 4 Midodrine;Atomoxetine
19 Mirabegron in Parkinson Disease and Impaired Cognition Recruiting NCT02536976 Phase 4 mirabegron;Placebo
20 Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? Recruiting NCT02806440 Phase 4 Low dose naltrexone;Placebo
21 Brain Perfusion & Oxygenation in Parkinson's Disease With NOH Not yet recruiting NCT03229174 Phase 4 Droxidopa;Placebo
22 TQL-block for Laparoscopic Hemicolectomy Not yet recruiting NCT03570541 Phase 4 Ropivacaine;Acetaminophen;Morphine;Saline
23 A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension Terminated NCT00046163 Phase 4 midodrine hydrochloride (ProAmatine®)
24 The Effect of Methylphenidate on Non-motor Symptoms and Postural Control in Parkinson's Disease. Terminated NCT01244269 Phase 4 Methylphenidate;Methylphenidate;Placebo 10;Placebo 20
25 Silodosin Versus Tamsulosin for Treatment of Ureteral Stones Terminated NCT02369744 Phase 4 Silodosin;Tamsulosin
26 Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty Completed NCT01707953 Phase 3 Midodrine;Placebo
27 Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Completed NCT00738062 Phase 3 Droxidopa;Placebo
28 A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease Completed NCT01176240 Phase 3 Droxidopa
29 A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa Completed NCT00782340 Phase 3 Placebo;Droxidopa
30 Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304) Completed NCT01132326 Phase 3 Droxidopa
31 Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) Completed NCT00633880 Phase 3 Placebo;Droxidopa
32 Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy Completed NCT01522235 Phase 2, Phase 3 Double blinded IVIg
33 Effect of Methylprednisolone on Orthostatic Intolerance and Heart Rate Variability in Hip-arthroplasty Patients Completed NCT02445898 Phase 2, Phase 3 Methylprednisolone;Isotonic Sodium Chloride
34 Efficacy and Safety of Primovist in Chinese Patients Completed NCT00526188 Phase 3 Gadoxetic Acid Disodium (Primovist, BAY86-4873)
35 Exhaled Levels of Nitric Oxide Completed NCT00753948 Phase 2, Phase 3 N-Nitro L-arginine-methylester (L-NAME)
36 A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication Completed NCT01195662 Phase 3 Dapagliflozin;Placebo matching Dapagliflozin
37 Deambulatory Epidural During the Labour Completed NCT02264834 Phase 3 Levobupivacaine 0.1% + Sufentanil 0.2µg/ml;Levobupivacaine 0.07% + Sufentanil 0.3µg/ml
38 Prevention of Low Blood Pressure in Persons With Tetraplegia Completed NCT00237770 Phase 2, Phase 3 N-Nitro L-arginine-methylester (L-NAME)
39 Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301) Completed NCT00446524 Phase 3 Valsartan + Amlodipine besilate
40 LEPU Renal Denervation System for Resistant Hypertension Completed NCT02536326 Phase 3
41 A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone Completed NCT00528879 Phase 3 Dapagliflozin;Placebo;Metformin
42 Stop Vasodepressor Drugs in Reflex Syncope Completed NCT02137278 Phase 3 Vasoactive drug therapies
43 Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Completed NCT01727713 Phase 3 Aripiprazole
44 Xenazine in Late Dyskinetic Syndrome With Neuroleptics Completed NCT01543321 Phase 3 Tetrabenazine;Placebo
45 Caffeine as a Therapy for Parkinson's Disease Completed NCT01738178 Phase 3 Caffeine;Placebo
46 Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA Recruiting NCT02071459 Phase 2, Phase 3 L-Threo DOPS;placebo
47 Treatment of Post-SCI Hypotension Recruiting NCT02919917 Phase 2, Phase 3 Midodrine Hydrochloride;Midodrine Hydrochloride
48 Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome Recruiting NCT03182725 Phase 3 Ivabradine;Placebo
49 An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease Recruiting NCT02542696 Phase 3 APL-130277
50 Preoperative Alpha Blockade for Pheochromocytoma Recruiting NCT03176693 Phase 3 Phenoxybenzamine;Doxazosin

Search NIH Clinical Center for Postural Hypotension

Genetic Tests for Postural Hypotension

Anatomical Context for Postural Hypotension

MalaCards organs/tissues related to Postural Hypotension:

41
Heart, Spinal Cord, Brain, Prostate, Eye, Liver, Skin

Publications for Postural Hypotension

Articles related to Postural Hypotension:

(show top 50) (show all 284)
# Title Authors Year
1
Intravascular lymphoma presenting with postural hypotension. ( 29378736 )
2018
2
Determining the causes of postural hypotension. ( 29358250 )
2018
3
Detecting Risk Of Postural hypotension (DROP): derivation and validation of a prediction score for primary care. ( 29678986 )
2018
4
Managing Postural Hypotension in Diabetic Autonomic Dysfunction When Adrenergic Drugs are Contraindicated: Case Report and Review of Literature. ( 29541560 )
2018
5
Systolic anterior motion of the mitral valve-the mechanism of postural hypotension following left intrapericardial pneumonectomy. ( 28523177 )
2017
6
Postural Hypotension and Cognitive Function in Older Adults. ( 28979924 )
2017
7
[OP.3C.04] PREDICTING POSTURAL HYPOTENSION, FALLS, AND COGNITIVE IMPAIRMENT: THE INCHIANTI STUDY. ( 27508664 )
2016
8
LB02.09: DETECTING RISK OF POSTURAL HYPOTENSION IN THE ELDERLY (DROP-HE): THE INCHIANTI STUDY. ( 26102956 )
2015
9
Blood pressure lowering therapy in older people: Does it really cause postural hypotension or falls? ( 25622817 )
2015
10
Deep Brain Stimulation Ameliorates Postural Hypotension in Parkinson's Disease. ( 26480982 )
2015
11
Seated postural hypotension. ( 26515671 )
2015
12
Factors associated with prevention of postural hypotension by leg compression bandaging. ( 24460143 )
2014
13
Postural Hypotension Associated with Nonelastic Pantyhose during Lymphedema Treatment. ( 25105033 )
2014
14
Postural hypotension in type 1 diabetes: the influence of glycemic control and duration of illness. ( 24553020 )
2014
15
A reversible cause of skin hyperpigmentation and postural hypotension. ( 23840983 )
2013
16
Implications of a vasodilatory human monoclonal autoantibody in postural hypotension. ( 24043632 )
2013
17
Supplementation with hydrocortisone on the 3rd-5th day following dexamethasone premedicated chemotherapy eliminated severe dizziness and postural hypotension. ( 22430411 )
2012
18
New therapies for postural hypotension. ( 22311904 )
2012
19
Influence of ABCB1 (P-glycoprotein) haplotypes on nortriptyline pharmacokinetics and nortriptyline-induced postural hypotension in healthy volunteers. ( 21999196 )
2012
20
QTc-interval, heart rate variability and postural hypotension as an indicator of cardiac autonomic neuropathy in type 2 diabetic patients. ( 22755273 )
2012
21
Bionic baroreceptor corrects postural hypotension in rats with impaired baroreceptor. ( 22851542 )
2012
22
Ischemic hepatitis secondary to hepatic artery steal in a patient with celiac artery stenosis and severe postural hypotension. ( 21538779 )
2011
23
Postural hypotension. ( 21680629 )
2011
24
Syncope is unrelated to supine and postural hypotension following prolonged exercise. ( 20886226 )
2011
25
A comparison of two treatment protocols in the management of exercise-associated postural hypotension: a randomised clinical trial. ( 20584756 )
2011
26
Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use. ( 20555135 )
2010
27
Postural hypotension as the initial presentation of fulminant right ventricular myocarditis. ( 20637387 )
2010
28
Bilateral bulbar palsy and postural hypotension following surgery for fourth ventricle subependymoma. ( 19766493 )
2009
29
Seating-induced postural hypotension is common in older patients with decompensated heart failure and may be prevented by lower limb compression bandaging. ( 18583904 )
2009
30
Investigation of postural hypotension due to static prolonged standing in female workers. ( 17721059 )
2007
31
Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug? ( 16862395 )
2006
32
Resetting of the arterial baroreflex increases orthostatic sympathetic activation and prevents postural hypotension in rabbits. ( 15878944 )
2005
33
Hypotension associated with prone body position: a possible overlooked postural hypotension. ( 16419647 )
2005
34
Dizziness produced by a potent 5HT(1A) receptor agonist (eptapirone) is not due to postural hypotension. ( 15619110 )
2005
35
Does increased arterial stiffness increase the risk for postural hypotension? ( 16247280 )
2005
36
Postural hypotension, hyponatremia, and salt and water intake: case reports. ( 15162884 )
2004
37
Lower limb compression bandaging is effective in preventing signs and symptoms of seating-induced postural hypotension. ( 15452389 )
2004
38
Care map 5: atypical antipsychotics. Postural hypotension. ( 15314918 )
2004
39
Symptomatic bradycardia and postural hypotension. ( 15537858 )
2004
40
Seated postural hypotension is common among older inpatients. ( 14673696 )
2003
41
Relative preservation of the renin-angiotensin-aldosterone system response to active orthostatism in type 2 diabetic patients with autonomic neuropathy and postural hypotension. ( 12817909 )
2003
42
Exercise-associated collapse: postural hypotension, or something deadlier? ( 20086459 )
2003
43
Are elderly haemodialysis patients at risk of falls and postural hypotension? ( 15160550 )
2003
44
Postural hypotension in hypertensive patients. ( 14763667 )
2003
45
Widespread cardiovascular autonomic dysfunction in primary amyloidosis: does spontaneous hyperventilation have a compensatory role against postural hypotension? ( 12433892 )
2002
46
Postural hypotension. New insights on pathophysiology and recent treatment advances. ( 12174522 )
2002
47
Noise-induced compensation for postural hypotension in primary autonomic failure. ( 12113953 )
2002
48
A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. ( 12082591 )
2002
49
The prevalence and association of neck (coat-hanger) pain and orthostatic (postural) hypotension in human spinal cord injury. ( 11926419 )
2002
50
Regulation of cerebral blood flow in patients with autonomic dysfunction and severe postural hypotension. ( 12402445 )
2002

Variations for Postural Hypotension

Expression for Postural Hypotension

Search GEO for disease gene expression data for Postural Hypotension.

Pathways for Postural Hypotension

GO Terms for Postural Hypotension

Cellular components related to Postural Hypotension according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.35 DBH INS NPPA REN SST
2 extracellular space GO:0005615 9.02 DBH INS NPPA REN SST

Biological processes related to Postural Hypotension according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.54 INS NPPA SST
2 response to insulin GO:0032868 9.32 INS NPPA
3 regulation of blood pressure GO:0008217 9.26 NPPA REN
4 cellular response to drug GO:0035690 9.16 DDC REN
5 response to drug GO:0042493 9.13 ABCB1 REN SST
6 catecholamine biosynthetic process GO:0042423 8.62 DBH DDC

Molecular functions related to Postural Hypotension according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 insulin-like growth factor receptor binding GO:0005159 8.96 INS REN
2 hormone activity GO:0005179 8.8 INS NPPA SST

Sources for Postural Hypotension

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....